The PE Ratio as of November 2024 (TTM) for Mereo BioPharma Group plc (MREO) is -12.40

According to Mereo BioPharma Group plc’s latest financial reports and current stock price. The company's current PE Ratio is -12.40. This represents a change of -67.76% compared to the average of -38.47 of the last 4 quarters.

Mereo BioPharma Group plc (MREO) Historical PE Ratio (quarterly & annually)

How has MREO PE Ratio performed in the past?

The mean historical PE Ratio of Mereo BioPharma Group plc over the last ten years is -5.95. The current -12.40 PE Ratio has changed 20.75% with respect to the historical average. Over the past ten years (40 quarters), MREO's PE Ratio was at its highest in in the March 2021 quarter at 58.34. The PE Ratio was at its lowest in in the March 2024 quarter at -66.69.

Mereo BioPharma Group plc (MREO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mereo BioPharma Group plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mereo BioPharma Group plc (MREO) Average PE Ratio

How has MREO PE Ratio performed in the past?

The current PE Ratio of Mereo BioPharma Group plc (MREO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mereo BioPharma Group plc (MREO) PE Ratio vs. Peers

How is MREO’s PE Ratio compared to its peers?

Mereo BioPharma Group plc’s PE Ratio is less than Terns Pharmaceuticals, Inc. (-5.12), less than PDS Biotechnology Corporation (-1.90), less than Inozyme Pharma, Inc. (-1.84), less than HOOKIPA Pharma Inc. (-0.62), greater than Day One Biopharmaceuticals, Inc. (-15.73), less than X4 Pharmaceuticals, Inc. (-4.05), less than Acumen Pharmaceuticals, Inc. (-1.74), less than Amylyx Pharmaceuticals, Inc. (-1.38), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Elevation Oncology, Inc. (-0.85), less than Hepion Pharmaceuticals, Inc. (-0.20),

Build a custom stock screener for Mereo BioPharma Group plc (MREO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mereo BioPharma Group plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mereo BioPharma Group plc (MREO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mereo BioPharma Group plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.